Petros Pharmaceuticals, Inc. (PTPI)

Petros Pharmaceuticals Revenue

Petros Pharmaceuticals had revenue of $1.42M in the quarter ending June 30, 2024, a decrease of -28.71%. This brings the company's revenue in the last twelve months to $4.12M, up 6.97% year-over-year. In the year 2023, Petros Pharmaceuticals had annual revenue of $5.82M, down -2.83%.

• Revenue (ttm): $4.12M
• Revenue Growth: +6.97%
• P/S Ratio: 0.37
• Revenue / Employee: $196,223
• Employees: 21
• Market Cap: 3.55M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	5.82M	-169.67K	-2.83%
Dec 31, 2022	5.99M	-1.82M	-23.29%
Dec 31, 2021	7.81M	-1.75M	-18.29%
Dec 31, 2020	9.56M	-6.02M	-38.63%
Dec 31, 2019	15.58M	1.53M	10.86%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.